Major drug co. seeks to improve health care in China

NEW YORK A U.S. drug maker is collaborating with a microfinance company to find ways to expand health care among the poor in China.

Pfizer announced that it would work with PlaNet Finance to conduct an in-depth research project on the health care needs of China’s working poor. The study will examine availability of medicines, patient purchasing patterns and levels of access to healthcare services.

“Pfizer’s partnership with PlaNet Finance is aligned with the strategy to expand our geographic reach across China,” said Jean-Michel Halfon, Pfizer Emerging Markets Business Unit president and general manager. “I am extremely confident that this partnership will also achieve the broader aim of identifying unique and workable solutions for the diverse medical needs of patients in emerging markets.”